BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 32246161)

  • 1. Liquid biopsies for multiple myeloma in a time of precision medicine.
    Ferreira B; Caetano J; Barahona F; Lopes R; Carneiro E; Costa-Silva B; João C
    J Mol Med (Berl); 2020 Apr; 98(4):513-525. PubMed ID: 32246161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid Biopsies as Non-Invasive Tools for Mutation Profiling in Multiple Myeloma: Application Potential, Challenges, and Opportunities.
    Heestermans R; Schots R; De Becker A; Van Riet I
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of
    Cayrefourcq L; Alix-Panabières C
    Expert Rev Mol Diagn; 2020 Sep; 20(9):913-919. PubMed ID: 32856493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders.
    Mithraprabhu S; Chen M; Savvidou I; Reale A; Spencer A
    Leukemia; 2021 Oct; 35(10):2771-2783. PubMed ID: 34262132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid Biopsies - the Clinics and the Molecules.
    Kubaczková V; Sedlarikova L; Bollová B; Sandecká V; Stork M; Pour L; Sevcikova S
    Klin Onkol; 2017; 30(Supplementum2):13-20. PubMed ID: 28903565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma.
    Manier S; Park J; Capelletti M; Bustoros M; Freeman SS; Ha G; Rhoades J; Liu CJ; Huynh D; Reed SC; Gydush G; Salem KZ; Rotem D; Freymond C; Yosef A; Perilla-Glen A; Garderet L; Van Allen EM; Kumar S; Love JC; Getz G; Adalsteinsson VA; Ghobrial IM
    Nat Commun; 2018 Apr; 9(1):1691. PubMed ID: 29703982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and future perspectives of liquid biopsies in genomics-driven oncology.
    Heitzer E; Haque IS; Roberts CES; Speicher MR
    Nat Rev Genet; 2019 Feb; 20(2):71-88. PubMed ID: 30410101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
    Moldogazieva NT; Zavadskiy SP; Terentiev AA
    Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach.
    Ricciardi E; Giordani E; Ziccheddu G; Falcone I; Giacomini P; Fanciulli M; Russillo M; Cerro M; Ciliberto G; Morrone A; Guerrisi A; Valenti F
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine.
    Rossi G; Ignatiadis M
    Cancer Res; 2019 Jun; 79(11):2798-2804. PubMed ID: 31109952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid Biopsy in Solid Malignancy.
    Scarlotta M; Simsek C; Kim AK
    Genet Test Mol Biomarkers; 2019 Apr; 23(4):284-296. PubMed ID: 30916594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Profiling of Liquid Biopsies for Precision Oncology.
    Gonzalez-Kozlova EE
    Adv Exp Med Biol; 2022; 1361():235-247. PubMed ID: 35230692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma.
    Garcés JJ; Bretones G; Burgos L; Valdes-Mas R; Puig N; Cedena MT; Alignani D; Rodriguez I; Puente DÁ; Álvarez MG; Goicoechea I; Rodriguez S; Calasanz MJ; Agirre X; Flores-Montero J; Sanoja-Flores L; Rodriguez-Otero P; Rios R; Martinez-Lopez J; Millacoy P; Palomera L; Del Orbe R; Pérez-Montaña A; El Omri H; Prosper F; Mateos MV; Rosiñol L; Blade J; Lahuerta JJ; Orfao A; Lopez-Otin C; San Miguel JF; Paiva B;
    Leukemia; 2020 Nov; 34(11):3007-3018. PubMed ID: 32475991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of Liquid Biopsies for Breast Cancer Screening, Diagnosis, and Response to Treatment.
    Eigeliene N; Saarenheimo J; Jekunen A
    Oncology; 2019; 96(3):115-124. PubMed ID: 30654364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research.
    Ramirez-Garrastacho M; Bajo-Santos C; Line A; Martens-Uzunova ES; de la Fuente JM; Moros M; Soekmadji C; Tasken KA; Llorente A
    Br J Cancer; 2022 Feb; 126(3):331-350. PubMed ID: 34811504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.
    Morrison GJ; Goldkorn A
    Curr Oncol Rep; 2018 Mar; 20(4):35. PubMed ID: 29572775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of liquid biopsy in precision medicine: opportunities and challenges.
    Wang J; Chang S; Li G; Sun Y
    Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsy for brain tumors.
    Shankar GM; Balaj L; Stott SL; Nahed B; Carter BS
    Expert Rev Mol Diagn; 2017 Oct; 17(10):943-947. PubMed ID: 28875730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid Biopsy Based on Circulating Cancer-Associated Cells: Bridging the Gap from an Emerging Concept to a Mainstream Tool in Precision Medicine.
    Jiménez-Zenteno AK; Cerf A
    Adv Biosyst; 2020 Feb; 4(2):e1900164. PubMed ID: 32293131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers.
    Addanki S; Meas S; Sarli VN; Singh B; Lucci A
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.